Figure 1From: Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration – evaluation in a clinical setting Proportion of reduced responders (black) and responders (white) in the various CNV types (occult, minimally classic, predominantly classic and RAP). The type of lesion was not related to the risk of a reduced response to treatment.Back to article page